In PAH, TGF-β1 is upregulated, particularly in PASMCs, with a stronger stimulatory effect observed in PAH PASMCs than in patients with chronic obstructive pulmonary disease [56, 95, 96]. This evidence concerns the gene TGFB1 and pulmonary arterial hypertension.